FR-194921 - CAS 202646-80-8
Catalog number: 202646-80-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Adenosine Receptor
FR-194921 is a potent, selective and orally active antagonist for central adenosine A1 receptors that displays high affinity and selectivity for the adenosine A1 receptor (Ki= 2.9 nM) and did not show species differences in binding affinity.
Publictions citing BOC Sciences Products
  • >> More
Solid powder
2-(1-methylpiperidin-4-yl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyridazin-3-one; FR-194921; FR 194921; FR194921; 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-3(2H)-pyridazinone
Canonical SMILES:
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adenosine Receptor Products

CAS 531506-36-2 A2B receptor antagonist 1

A2B receptor antagonist 1
(CAS: 531506-36-2)

A potent antagonist of A2B adenosine receptor

CAS 133058-72-7 KFM19

(CAS: 133058-72-7)

KFM19 is a selective adenosine A1-antagonist with good bioavailability (IC50= 50 nM).

CAS 1246018-36-9 ST4206

(CAS: 1246018-36-9)

ST4206 is a potent adenosine A2A antagonist. ST4206 showed neuroprotective effects against rotenone induced alterations instriatal slice preparations,supporting...

Neladenoson dalanate
(CAS: 1239309-58-0)

Neladenoson dalanate is a potent adenosine A1 receptor agonist originated by Bayer HealthCare Pharmaceuticals. It is applicated for the treatment of Chronic hea...

CGS 21680
(CAS: 120225-54-9)

CGS 21680, an A2 adenosine receptor selective agonist, has been found to be probably effective in inducing vasorelaxation and increasing in heart rate.

CAS 442908-10-3 Vipadenant

(CAS: 442908-10-3)

Adenosine A2 receptor antagonists; Immunosuppressants

CAS 139180-30-6 ZM 241385

ZM 241385
(CAS: 139180-30-6)

Potent, highly selective A2A antagonist

CAS 890087-21-5 LUF 6000

LUF 6000
(CAS: 890087-21-5)

LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR). It was found to be an allosteric enhancer of Emax. It exerted an Emax-enhancing effe...

CAS 96392-15-3 PD-117519

(CAS: 96392-15-3)

PD-117519 is a N6-substituted adenosine receptor agonist. It shows oral antihypertensive activity in pharmacological animal models. It is used as a potential an...

CAS 53885-35-1 Ticlopidine Hydrochloride

Ticlopidine Hydrochloride
(CAS: 53885-35-1)

Ticlopidine HCl is an P2 receptor inhibitor against ADP-induced platelet aggregation with IC50 of ~2 μM.

CAS 152918-18-8 CF-101

(CAS: 152918-18-8)

CF101 is a specific agonist to the A3 adenosine receptor, which inhibits the development of colon carcinoma growth in cell cultures and xenograft murine models...

CAS 121241-87-0 N-0861 racemate

N-0861 racemate
(CAS: 121241-87-0)

N-0861 racemate is the racemate of N-0861 which appears to be an effective and selective A1 adenosine receptor antagonist in humans.

CAS 142344-87-4 GP531

(CAS: 142344-87-4)

GP531 is a novel riboside with similar structural and anti-ischemic properties to the adenosine-regulating agent (ARA) acadesine.

CAS 58-55-9 Theophylline

(CAS: 58-55-9)

Theophylline is a methylated xanthine derivative; that functions as a nonselective PDE4 inhibitor and nonselective adenosine receptor antagonist.

CAS 870070-55-6 Tozadenant

(CAS: 870070-55-6)

An orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor

CAS 1202402-40-1 CPI-444

(CAS: 1202402-40-1)

CPI-444 is a potent, orally available, selective antagonist of the adenosine A2A receptor that has been well tolerated in Ph 1/1b studies in non-oncology indica...

(CAS: 851087-60-0)

ASP-5854 is an adenosine A1 and A2A receptor antagonist receptor. It has therapeutic potential for the treatment of Parkinson's disease to ameliorate motor defi...

CAS 136199-02-5 KW-3902

(CAS: 136199-02-5)

KW-3902 is a selective adenosine A1 receptor antagonist under the development of Kyowa Hakko and Merck & Co. It displays 890-fold selectivity for rat A1 recepto...

(CAS: 871108-05-3)

Trabodenoson is a selective adenosine A1 receptor agonist. Trabodenoson can significantly reduce IOP in glaucoma and OHT patients. Phase III clinical trials for...

(CAS: 166374-49-8)

Naxifylline, a xanthine derivative, has been found to be an adenosine A1 receptor antagonist as well as diuretic agent that was once studied in heart failure an...

Quick Inquiry

Verification code

Featured Items